What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Corey Cutler mainly focuses on Transplantation, Internal medicine, Hematopoietic stem cell transplantation, Surgery and Immunology.
His Transplantation research includes elements of Clinical trial, Disease, Myelodysplastic syndromes, Stem cell and Transplantation Conditioning.
Corey Cutler has included themes like Gastroenterology and Oncology in his Internal medicine study.
His Hematopoietic stem cell transplantation research incorporates themes from Thrombotic microangiopathy, Calcineurin, Hematology, Quality of life and Methylprednisolone.
His studies in Surgery integrate themes in fields like Leukemia and Incidence.
As a part of the same scientific family, Corey Cutler mostly works in the field of Immunology, focusing on Haematopoiesis and, on occasion, Mutation, Young adult, Cancer research and Ex vivo.
His most cited work include:
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report (3120 citations)
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease (2220 citations)
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease (766 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Graft-versus-host disease and Immunology.
His biological study spans a wide range of topics, including Gastroenterology, Surgery and Oncology.
The Gastroenterology study combines topics in areas such as Regimen, Umbilical cord, Tacrolimus, Neutrophil Engraftment and Platelet Engraftment.
His research in Transplantation intersects with topics in Clinical trial, Sirolimus, Disease, Stem cell and Leukemia.
His Hematopoietic stem cell transplantation study also includes
- Cohort that intertwine with fields like Quality of life,
- Hazard ratio which is related to area like Proportional hazards model.
His Graft-versus-host disease research includes elements of Immunosuppression and Ibrutinib.
He most often published in these fields:
- Internal medicine (67.15%)
- Transplantation (63.48%)
- Hematopoietic stem cell transplantation (40.67%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (67.15%)
- Transplantation (63.48%)
- Graft-versus-host disease (37.48%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Transplantation, Graft-versus-host disease, Hematopoietic stem cell transplantation and Immunology.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Oncology.
His work focuses on many connections between Oncology and other disciplines, such as Myeloid leukemia, that overlap with his field of interest in Leukemia.
Corey Cutler interconnects Hematopoietic cell, Clinical trial, Cyclophosphamide, Disease and Hazard ratio in the investigation of issues within Transplantation.
His work carried out in the field of Graft-versus-host disease brings together such families of science as Refractory, Sirolimus, T cell, Adverse effect and CD8.
His Hematopoietic stem cell transplantation research is multidisciplinary, incorporating elements of Cancer and Incidence.
Between 2017 and 2021, his most popular works were:
- α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease. (42 citations)
- Management of important adverse events associated with inotuzumab ozogamicin: expert panel review. (36 citations)
- Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission (32 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
Internal medicine, Transplantation, Graft-versus-host disease, Hematopoietic stem cell transplantation and Disease are his primary areas of study.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology and Oncology.
His Transplantation research is multidisciplinary, incorporating perspectives in Clinical trial, Prospective cohort study, Retrospective cohort study, Complication and Leukemia.
Corey Cutler combines subjects such as Adverse effect, CD8, Immunology, Ibrutinib and Aldesleukin with his study of Graft-versus-host disease.
His work in the fields of Busulfan overlaps with other areas such as Medicaid.
The various areas that Corey Cutler examines in his Disease study include Oral mucosa, Discontinuation, Confidence interval, Intensive care medicine and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
